• I-BET151 (GSK1210151A) Assay Guide

  2026-09-22

  A scenario-based guide to using I-BET151 (GSK1210151A), SKU B1500, in viability, apoptosis, proliferation, and cell-cycle studies. It connects BET biology with practical stock preparation, assay controls, interpretation, and evidence-based reagent selection.

• Acifran: HCAR Agonist for Lipid Research

  2026-09-22

  Acifran is the research compound (R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid and a selective agonist of HM74A/GPR109A and GPR109B. Recent cryo-EM work defines how acifran engages HCAR2 and HCAR3, supporting its use in lipid signaling pathway modulation and receptor-selectivity studies.

• Dual Luciferase Reporter Gene System: Stress Assays

  2026-09-21

  The Dual Luciferase Reporter Gene System offers a rigorous way to separate promoter activation from experimental noise in stress-response research. This guide applies dual-reporter logic to the SlSTOP1–SlSLAH1–SlSLAH2 pathway in tomato while defining practical limits for plant applications.

• DiscoveryProbe FDA-approved Drug Library: Assay Logic

  2026-09-21

  Learn how the DiscoveryProbe FDA-approved Drug Library can support mechanism-aware drug repositioning screening. Using norovirus–NINJ1 biology as a model, this article shows how orthogonal readouts turn phenotypic hits into testable pharmacological hypotheses.

• HyperTrap Heparin HP Column for Stemness Research

  2026-09-20

  Use the HyperTrap Heparin HP Column to enrich soluble heparin-binding proteins, growth factors, and pathway-associated cofactors while keeping CCR7–Notch1 measurements analytically separate. Its fine-particle HyperChrom Heparin HP Agarose format supports high-resolution fractionation, scalable loading, and practical cleanup of complex biological samples.

• Ivermectin Beyond the Label: Translational Assay Strategy

  2026-09-19

  Ivermectin is best understood not only as an established broad-spectrum anti-parasitic, but also as a disciplined reference compound for translational assay design. This article connects its parasitology utility with the mechanistic lessons of Gasdermin C biology in pancreatic cancer without overstating unproven oncology activity.

• Dronedarone: Atrial Assay Interpretation Guide

  2026-09-18

  Dronedarone (Multaq) is more than a broad-spectrum antiarrhythmic comparator: its apparent lack of direct KCa2.2/KCa2.3 inhibition can sharpen assay design. This guide translates automated patch-clamp evidence, chemical handling data, and target-deconvolution principles into better atrial fibrillation treatment research.

• ZNF263, ULK1 Autophagy, and ICC Proliferation

  2026-09-18

  This study identifies ZNF263 as a transcriptional driver of intrahepatic cholangiocarcinoma (ICC) proliferation and links its activity to enhancer-mediated activation of ULK1 and autophagy. By combining genomic occupancy mapping, transcriptomics, reporter assays, cellular phenotyping, and xenograft analysis, the authors define a ZNF263–ULK1 axis with potential prognostic and therapeutic relevance.

• Ivermectin Workflows for Parasitology Research

  2026-09-17

  Build more reproducible parasite assays with Ivermectin by controlling solvent, concentration, exposure time, and orthogonal readouts. This guide also shows how a Gasdermin C cancer study can improve assay logic without implying that Ivermectin is an oncology treatment or GSDMC inhibitor.

• A-1210477: MCL-1 Inhibitor Workflow

  2026-09-17

  A-1210477 enables mechanism-focused studies of MCL-1-dependent cancer cell survival, from BIM displacement to mitochondrial apoptosis. This practical guide covers compound handling, dose-response design, apoptosis readouts, combination experiments, and troubleshooting for reproducible cancer research.

• Norepinephrine Bitartrate in Translational Research

  2026-09-16

  A mechanistic and strategic guide to using (-)-Norepinephrine (+)-bitartrate for adrenergic receptor signaling, cardiovascular models, binding studies, and translational research design.

• AO/PI Double Staining Kit for Cell Fate Analysis

  2026-09-16

  The AO/PI Double Staining Kit distinguishes viable, apoptotic, and necrotic cells in one rapid fluorescent workflow. It is especially useful for treatment-response studies, including melanoma experiments where apoptosis findings benefit from orthogonal biochemical and morphological validation.

• Antiarrhythmic Drugs and Cardiac SK Channels in AF

  2026-09-15

  The reference study systematically tested established antiarrhythmic drugs against human small-conductance calcium-activated potassium channels, a potentially atrial-selective target in atrial fibrillation. Its results indicate that dofetilide and propafenone can inhibit KCa2 channels in vitro, whereas the concentrations required are generally too high to explain their clinical antiarrhythmic activity; Dronedarone was not identified as a clinically relevant KCa2 inhibitor.

• AG-126 (Tyrphostin AG-126): ERK Research Guide

  2026-09-15

  AG-126, also called Tyrphostin AG-126, is a selective ERK1/2 phosphorylation inhibitor used in mechanistic research. Product data describe in vitro cytokine release inhibition and in vivo activity in a pneumococcal cell wall inflammation model, but no clinical evidence supports medical use.

• o-Agatoxin IVA and Excitotoxicity in Cortical Neurons

  2026-09-14

  Lustig, Ahern, and Greenberg tested whether the P- and Q-type calcium-channel antagonist o-agatoxin IVA could protect cultured cortical neurons from excitotoxic injury caused by veratridine, ouabain, or NMDA. The central finding was negative but important: inhibiting toxin-sensitive calcium entry or glutamate release did not reliably prevent neuronal damage, showing that presynaptic channel blockade alone is not equivalent to neuroprotection.

8373 records 1/559 page Next 12345 下5页 Last page